These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22190350)

  • 1. Use of ordered mesoporous silica to enhance the oral bioavailability of ezetimibe in dogs.
    Kiekens F; Eelen S; Verheyden L; Daems T; Martens J; Van Den Mooter G
    J Pharm Sci; 2012 Mar; 101(3):1136-44. PubMed ID: 22190350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Performance of Fenofibrate Formulated With Ordered Mesoporous Silica Versus 2-Marketed Formulations: A Comparative Bioavailability Study in Beagle Dogs.
    Bukara K; Schueller L; Rosier J; Daems T; Verheyden L; Eelen S; Martens JA; Van den Mooter G; Bugarski B; Kiekens F
    J Pharm Sci; 2016 Aug; 105(8):2381-5. PubMed ID: 27364460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.
    Mellaerts R; Mols R; Jammaer JA; Aerts CA; Annaert P; Van Humbeeck J; Van den Mooter G; Augustijns P; Martens JA
    Eur J Pharm Biopharm; 2008 May; 69(1):223-30. PubMed ID: 18164930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel mesoporous nanomatrix-supported lipid bilayers for oral sustained delivery of the water-insoluble drug, lovastatin.
    Zhang Y; Zhang H; Che E; Zhang L; Han J; Yang Y; Wang S; Zhang M; Gao C
    Colloids Surf B Biointerfaces; 2015 Apr; 128():77-85. PubMed ID: 25731096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug release.
    Vialpando M; Aerts A; Persoons J; Martens J; Van Den Mooter G
    J Pharm Sci; 2011 Aug; 100(8):3411-3420. PubMed ID: 21387318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
    Chen B; Wang Z; Quan G; Peng X; Pan X; Wang R; Xu Y; Li G; Wu C
    Int J Nanomedicine; 2012; 7():199-209. PubMed ID: 22275835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica].
    Quan GL; Chen B; Wang ZH; Wu H; Huang XT; Wu LN; Wu CB
    Yao Xue Xue Bao; 2012 Feb; 47(2):239-43. PubMed ID: 22512038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.
    Bali V; Ali M; Ali J
    J Drug Target; 2010 Aug; 18(7):506-19. PubMed ID: 20067438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica.
    Wang Z; Chen B; Quan G; Li F; Wu Q; Dian L; Dong Y; Li G; Wu C
    Int J Nanomedicine; 2012; 7():5807-18. PubMed ID: 23209366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation.
    Dixit RP; Nagarsenker MS
    Eur J Pharm Sci; 2008 Oct; 35(3):183-92. PubMed ID: 18652892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CapsMorph® technology for oral delivery--theory, preparation and characterization.
    Wei Q; Keck CM; Müller RH
    Int J Pharm; 2015 Mar; 482(1-2):11-20. PubMed ID: 25445968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impregnation of Fenofibrate on mesoporous silica using supercritical carbon dioxide.
    Bouledjouidja A; Masmoudi Y; Van Speybroeck M; Schueller L; Badens E
    Int J Pharm; 2016 Feb; 499(1-2):1-9. PubMed ID: 26732521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
    Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
    Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin.
    Zhang Y; Wang H; Gao C; Li X; Li L
    Eur J Pharm Sci; 2013 Aug; 49(5):864-72. PubMed ID: 23791638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability.
    Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S
    Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A solid-state NMR study of amorphous ezetimibe dispersions in mesoporous silica.
    Vogt FG; Roberts-Skilton K; Kennedy-Gabb SA
    Pharm Res; 2013 Sep; 30(9):2315-31. PubMed ID: 23794037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
    Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
    Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.